Skye Bioscience, Inc. Other Current Assets
Skye Bioscience, Inc. (SKYE) had Other Current Assets of $479.58 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Current $479.58K.
- 2026-03-31: Other Assets, Current $234.81K.
- 2025-12-31: Other Assets, Current $852.04K.
- 2025-09-30: Other Assets, Current $900.17K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $479.58K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $234.81K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $852.04K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $900.17K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $733.42K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.23M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.21M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $2.65M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.71M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $1.51M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $1.12M 10-K · filed 2025-03-20 | $888.93K 10-K · filed 2024-03-22 |
| 2023-09-30 | $867.92K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.06M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $820.01K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $481.59K 10-K · filed 2024-03-22 | $412.02K 10-K · filed 2023-03-31 |
| 2022-09-30 | $143.86K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $113.19K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $109.75K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $56.87K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $275.00 10-K · filed 2022-03-28 | |
| 2020-09-30 | $3.33K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $4.64K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $3.89K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $7.55K 10-K · filed 2021-03-02 | |
| 2019-09-30 | $3.38K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.61K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.61K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.61K 10-K · filed 2020-03-23 | |
| 2018-09-30 | $2.61K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $2.61K 10-Q · filed 2018-08-10 | |
| 2017-09-30 | $6.18K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $6.18K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $7.01K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $7.01K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $28.63K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $28.63K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $28.63K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $36.13K 10-K · filed 2017-03-10 | |
| 2015-09-30 | $31.11K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $32.11K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $32.11K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $36.58K 10-K · filed 2016-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |